Filing Details
- Accession Number:
- 0000905718-21-001521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 18:00:32
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-22 18:00:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1708331 | Virpax Pharmaceuticals Inc. | VRPX | Pharmaceutical Preparations (2834) | 821510982 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818483 | P. Anthony Mack | 1055 Westlakes Drive, Suite 300 Berwyn PA 19312 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 Par Value | Acquisiton | 2021-11-18 | 25,125 | $3.99 | 176,812 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.00001 Par Value | 2,730,438 | Indirect | By Virpax Pharmaceuticals, LLC |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $3.935 to $4.10 per share, inclusive. The Reporting Person undertakes to provide to Virpax Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- The Reporting Person owns 88.8888% of the outstanding member units of Virpax Pharmaceuticals, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Billionaire Hedge Funds
